Utilizing cell-free methylomes to inform clinical scenarios in renal cell carcinoma

Ended Project Grant Awarded Last action

Award ID
W81XWH2110339
Recipient
Awarding agency
Obligated
$1,156,892

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Boston, MA 02115, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Dana-Farber Cancer Institute, Inc. (DFCI) was awarded a $1,156,892 Project Grant from the Department of the Army Medical Command to utilize cell-free methylomes to inform clinical scenarios in renal cell carcinoma. The grant was awarded on August 15, 2021 with a completion date of August 14, 2024 under the Military Medical Research and Development program (CFDA 12.420).

Through this funding, DFCI will apply its work on cell-free methylomes, a non-invasive method to analyze DNA methylation patterns in blood plasma, to better understand renal cell carcinoma and improve clinical decision making for service members and the general public. The Military Medical Research and Development program aims to transform health care through innovative biomedical research that investigates medical solutions for battlefield wounds and other health issues.

Quick answers

Who received award W81XWH2110339?

W81XWH2110339 was awarded to Dana-Farber Cancer Institute, Inc. by Medical Command (Department of the Army) on August 15, 2021.

How much is award W81XWH2110339 worth?

$1,156,892 has been obligated on W81XWH2110339.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login